Lenvatinib Mesylate and Vincristine liposome Intravenous
Determining the interaction of Lenvatinib Mesylate and Vincristine liposome Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: vincristine liposome
Brand name: Marqibo
Synonyms: Vincristine liposome, VinCRIStine (Liposomal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Vincristine Sulfate
- Lenvatinib Mesylate-Vinorelbine
- Lenvatinib Mesylate-Vinorelbine Intravenous
- Lenvatinib Mesylate-Vinorelbine Tartrate
- Lenvatinib Mesylate-Vinorelbine, Concentrate
- Lenvatinib Mesylate-Vioform Hydrocortisone Mild Topical
- Vincristine liposome Intravenous-Lenvima
- Vincristine liposome Intravenous-Lenvima (14 MG Daily Dose)
- Vincristine liposome Intravenous-Lenvima (18 MG Daily Dose)
- Vincristine liposome Intravenous-Lenvima (20 MG Daily Dose)
- Vincristine liposome Intravenous-Lenvima (24 MG Daily Dose)
- Vincristine liposome Intravenous-Lenvima (8 MG Daily Dose)